CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells from MDS patients against primary MDS and MDSC CD33+ targets. Blood. 2014.
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry. N Engl J Med. 2014;371(4):339-348.
Analysis of a genetic polymorphism in the costimulatory molecule TNFSF4 with HSCT outcomes. Biol Blood Marrow Transplant. 2015.